379P - Phase II studies of AZD1775, a WEE1 kinase inhibitor, and chemotherapy in non-small-cell lung cancer (NSCLC): Lead-in cohort results
| Autor: | Spigel, D.R., Dakhil, S., Beck, J.T., Sadiq, A., Menon, S., Webb, C.D., Tsai, F.Y., Johnson, M., Jones, S.F., Greenlees, C., Stults, D.M., Strickland, D., Cook, C., Mugundu, G.M., Laing, N.M., French, T., Burris, H.A. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi121-vi121 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|